Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
6 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to ARS Pharmaceuticals, Inc.’s names, not what it holds today.
Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 1 in 2023
Applications published
27
1 of them in 2025
Names they are printed under
4
a former name, its own name, a subsidiary
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Silverback Therapeutics, Inc. a former name
named as the applicant on its applications, in US
21 publishedSILVERBACK THERAPEUTICS, INC. a former name
US, as the owner printed on each patent
2 publishedARS PHARMACEUTICALS INC. its own name
named as the applicant on its applications, in US
3 publishedARS Pharmaceuticals Operations, Inc. a subsidiary
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jan 3, 2023 | 11,541,126 | Anti-ASGR1 antibody TLR8 agonist comprising conjugates and uses thereof | Pharmaceuticals | SILVERBACK THERAPEUTICS, INC. |
| Nov 23, 2021 | 11,179,473 | Nectin-4 antibody conjugates and uses thereof | Pharmaceuticals | SILVERBACK THERAPEUTICS, INC. |
| Dec 31, 2019 | 10,519,131 | Benzazepine compounds, conjugates, and uses thereof | Organic fine chemistry | SILVERBACK THERAPEUTICS, INC. |
| Oct 15, 2019 | 10,442,790 | Benzazepine compounds, conjugates, and uses thereof | Organic fine chemistry | SILVERBACK THERAPEUTICS, INC. |
| Oct 1, 2019 | 10,428,045 | Benzazepine compounds, conjugates, and uses thereof | Organic fine chemistry | SILVERBACK THERAPEUTICS, INC. |
| Mar 26, 2019 | 10,239,862 | Benzazepine compounds, conjugates, and uses thereof | Organic fine chemistry | SILVERBACK THERAPEUTICS, INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 21, 2025 | 2025/0262173 | INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS OF USE | Pharmaceuticals | ARS Pharmaceuticals Operations, Inc. |
| Mar 2, 2023 | 2023/0062712 | ANTI-ASGR1 ANTIBODY CONJUGATES AND USES THEREOF | Pharmaceuticals | Silverback Therapeutics, Inc. |
| Nov 17, 2022 | 2022/0362396 | AMINO-PYRAZINECARBOXAMIDE COMPOUNDS, CONJUGATES, AND USES THEREOF | Pharmaceuticals | Silverback Therapeutics, Inc. |
| Oct 13, 2022 | 2022/0323596 | ANTIBODY CONJUGATES OF TOLL-LIKE RECEPTOR AGONISTS | Pharmaceuticals | Silverback Therapeutics, Inc. |
| Aug 11, 2022 | 2022/0249685 | ANTI-MESOTHELIN ANTIBODIES AND IMMUNOCONJUGATES THEREOF | Pharmaceuticals | Silverback Therapeutics, Inc. |
| Jun 2, 2022 | 2022/0169660 | CYCLIC AMINO-PYRAZINECARBOXAMIDE COMPOUNDS AND USES THEREOF | Organic fine chemistry | Silverback Therapeutics, Inc. |
| Apr 7, 2022 | 2022/0105196 | NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF | Pharmaceuticals | Silverback Therapeutics, Inc. · patent 12,364,768 granted from it |
| Feb 17, 2022 | 2022/0048895 | SUBSTITUTED BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF | Pharmaceuticals | Silverback Therapeutics, Inc. |
| Sep 9, 2021 | 2021/0275683 | NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF | Pharmaceuticals | Silverback Therapeutics, Inc. · patent 11,179,473 granted from it |
| May 27, 2021 | 2021/0154317 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | Pharmaceuticals | Silverback Therapeutics, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.